Search Results - "DeFlores, Robin"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    DeepAtrophy: Teaching a neural network to detect progressive changes in longitudinal MRI of the hippocampal region in Alzheimer's disease by Dong, Mengjin, Xie, Long, Das, Sandhitsu R., Wang, Jiancong, Wisse, Laura E.M., deFlores, Robin, Wolk, David A., Yushkevich, Paul A.

    Published in NeuroImage (Orlando, Fla.) (01-11-2021)
    “…Measures of change in hippocampal volume derived from longitudinal MRI are a well-studied biomarker of disease progression in Alzheimer's disease (AD) and are…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Regional deep atrophy: Using temporal information to automatically identify regions associated with Alzheimer’s disease progression from longitudinal MRI by Dong, Mengjin, Xie, Long, Das, Sandhitsu R., Wang, Jiancong, Wisse, Laura E.M., deFlores, Robin, Wolk, David A., Yushkevich, Paul A.

    Published in Imaging neuroscience (Cambridge, Mass.) (18-09-2024)
    “…Longitudinal assessment of brain atrophy, particularly in the hippocampus, is a well-studied biomarker for neurodegenerative diseases, such as Alzheimer’s…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    Regional Deep Atrophy: a Self-Supervised Learning Method to Automatically Identify Regions Associated With Alzheimer's Disease Progression From Longitudinal MRI by Dong, Mengjin, Xie, Long, Das, Sandhitsu R, Wang, Jiancong, Wisse, Laura E. M, deFlores, Robin, Wolk, David A, Yushkevich, Paul A

    Published 10-04-2023
    “…Longitudinal assessment of brain atrophy, particularly in the hippocampus, is a well-studied biomarker for neurodegenerative diseases, such as Alzheimer's…”
    Get full text
    Journal Article
  9. 9

    DeepAtrophy: Teaching a Neural Network to Differentiate Progressive Changes from Noise on Longitudinal MRI in Alzheimer's Disease by Dong, Mengjin, Xie, Long, Das, Sandhitsu R, Wang, Jiancong, Wisse, Laura E. M, deFlores, Robin, Wolk, David A, Yushkevich, Paul

    Published 24-10-2020
    “…Volume change measures derived from longitudinal MRI (e.g. hippocampal atrophy) are a well-studied biomarker of disease progression in Alzheimer's Disease (AD)…”
    Get full text
    Journal Article